Sharper & Granite LLC Increases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Sharper & Granite LLC boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.8% in the fourth quarter, Holdings Channel reports. The fund owned 6,250 shares of the financial services provider’s stock after buying an additional 170 shares during the quarter. Sharper & Granite LLC’s holdings in iShares Biotechnology ETF were worth $826,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Security National Bank of SO Dak grew its stake in iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares in the last quarter. SPC Financial Inc. grew its position in shares of iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares in the last quarter. Werba Rubin Papier Wealth Management increased its stake in shares of iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after buying an additional 76 shares during the last quarter. Capital Investment Advisors LLC raised its holdings in iShares Biotechnology ETF by 1.0% in the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after acquiring an additional 99 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. boosted its stake in iShares Biotechnology ETF by 6.0% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock valued at $242,000 after acquiring an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.0 %

Shares of IBB stock opened at $134.02 on Tuesday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The company’s 50-day simple moving average is $137.95 and its 200-day simple moving average is $141.99.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.